Recent Posts

Dr Reddy’s gets to launch Allegra D-24, stock up 2.7%

Dr Reddy’s Laboratories can now launch the generic version of Allegra D-24, an extended release version of blockbuster drug Allegra. It won a key case in the US courts which will allow it to go ahead with a launch, with the possibility of a compensation being awarded by the court, but with the risk of an appeal, which could see the matter well drag on further.

Continue Reading →

Filed under: , , , , , ,